(Q24800799)
Statements
Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus) (English)
0 references
2005
0 references
3
0 references
1
0 references
7
0 references
1 reference
1 reference
1 reference
1 reference